Lactobacillus casei exerts anti-proliferative effects accompanied by apoptotic cell death and up-regulation of TRAIL in colon carcinoma cells

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Tiptiri Kourpeti, Angeliki ^a   Spyridopoulou, Katerina ^a   Santarmaki, Valentina ^a   Aindelis, Georgios ^a   Tompoulidou, Evgenia ^a   Lamprianidou, Eleftheria E ^a   Saxami, Georgia ^a   Ypsilantis, Petros ^a   Lampri, Evangeli S ^b   Simopoulos, Constantinos ^a   Kotsianidis, Ioannis ^a   Galanis, Alex ^a   Kourkoutas, Yiannis ^a   Dimitrellou, Dimitra ^a   Chlichlia, Katerina ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; SURVIVIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; BIRC5 PROTEIN, HUMAN; CYCLIN D1; INHIBITOR OF APOPTOSIS PROTEIN; PROBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL LINE; CELL VIABILITY; COLON CARCINOMA; COLONY FORMING UNIT; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LACTOBACILLUS CASEI; MITOSIS INHIBITION; MOUSE; NONHUMAN; UPREGULATION; ANIMAL; BACTERIUM ADHERENCE; CELL PROLIFERATION; CELL SURVIVAL; COLON TUMOR; DISEASE MODEL; GENETICS; METABOLISM; PH; PHYSIOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; APOPTOSIS; BACTERIAL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; CYCLIN D1; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HUMANS; HYDROGEN-ION CONCENTRATION; INHIBITOR OF APOPTOSIS PROTEINS; LACTOBACILLUS CASEI; MICE; PROBIOTICS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UP-REGULATION;

EID: 84959180382     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147960     Document Type: Article

References (69)

1. Rafter J. The effects of probiotics on colon cancer development. Nutr Res Rev. 2004; 17: 277-284. doi: 10.1079/NRR200484 PMID: 19079931
2. Marco ML, Pavan S, Kleerebezem M. Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol. 2006; 17(2): 204-210. PMID: 16510275
3. Zhu Y, Michelle Luo T, Jobin C, Young HA. Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett. 2011; 309(2): 119-127. doi: 10.1016/j.canlet.2011.06.004 PMID: 21741763
4. Walsh CJ, Guinane CM, O'Toole PW, Cotter PD. Beneficial modulation of the gut microbiota. FEBS Lett. 2014; 588(22): 4120-4130. doi: 10.1016/j.febslet.2014.03.035 PMID: 24681100
5. Zhong L, Zhang X, Covasa M. Emerging roles of lactic acid bacteria in protection against colorectal cancer. World J Gastroenterol. 2014; 20(24):7878-7886. doi: 10.3748/wjg.v20.i24.7878 PMID: 24976724
6. Rauch M, Lynch SV. Probiotic manipulation of the gastrointestinal microbiota. Gut Microbes. 2010; 1 (5): 335-338. PMID: 21327043
7. Shida K, Nanno M, Nagata S. Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes. 2011; 2(2): 109-114. PMID: 21637028
8. Serban DE. Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics. Cancer Lett. (2014); 345(2): 258-270. doi: 10.1016/j.canlet.2013.08.013 PMID: 23981580
9. Pagnini C, Corleto VD, Mangoni ML, Pilozzi E, Torre MS, Marchese R, et al. Alteration of local microflora and α-defensins hyper-production in colonic adenoma mucosa. J Clin Gastroenterol. 2011; 45(7): 602-610. doi: 10.1097/MCG.0b013e31820abf29 PMID: 21346603
10. Neish AS. The microbiota and colonic neoplasia. An emerging link? J Clin Gastroenterol. 2011; 45(7): 571. doi: 10.1097/MCG.0b013e318219221d PMID: 21555952
11. Clevers H. At the crossroads of inflammation and cancer. Cell. 2004; 118: 671-674. PMID: 15369667
12. LeBlanc A, LeBlanc J. Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications. World J Gastroenterol. 2014; 20(33): 16518-16528.
13. Oelschlaeger TA. Mechanisms of probiotic actions - A review. Int J Med Microbiol. 2010; 300(1): 57-62. doi: 10.1016/j.ijmm.2009.08.005 PMID: 19783474
14. Tsilingiri K, Rescigno M. Postbiotics: what else? Benef Microbes. 2013; 4(1): 101-107. doi: 10.3920/ BM2012.0046 PMID: 23271068
15. Yan F, Cao H, Cover TL, Washington MK, Shi Y, Liu L, et al. Colon-specific delivery of a probioticderived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest. 2011; 121(6): 2242-2253. doi: 10.1172/JCI44031 PMID: 21606592
16. Cicenia A, Scirocco A, Carabotti M, Pallotta L, Marignani M, Severi C. Postbiotic activities of lactobacilli-derived factors. J Clin Gastroenterol. 2014; 48 Suppl 1: S18-22. doi: 10.1097/MCG. 0000000000000231 PMID: 25291118
17. Tuo YF, Zhang LW, Yi HX, Zhang YC, Zhang WQ, Han X et al. Antiproliferative effect of wild Lactobacillus strains isolated from fermented foods on HT-29 cells. J. Dairy Sci. 2010; 93: 2362-2366. doi: 10.3168/jds.2010-3069 PMID: 20494143
18. Liu CT, Chu FJ, Chou CC, Yu RC. Antiproliferative and anticytotoxic effects of cell fractions and exopolysaccharides from Lactobacillus casei 01. Mutat Res. 2011; 721(2): 157-162. doi: 10.1016/j.mrgentox. 2011.01.005 PMID: 21262385
19. Wang SM, Zhang LW, Fan RB, Han X, Yi HX, Zhang LL, et al. Induction of HT-29 cells apoptosis by lactobacilli isolated from fermented products. Res Microbiol. 2014; 165(3): 202-214. doi: 10.1016/j.resmic. 2014.02.004 PMID: 24631592
20. Choi SS, Kim Y, Han KS, You S, Oh S, Kim SH. Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro. Lett Appl Microbiol. 2006; 42(5): 452-458. PMID: 16620202
21. Orlando A, Refolo MG, Messa C, Amati L, Lavermicocca P, Guerra V, et al. Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines. Nutr Cancer. 2012; 64(7): 1103-1111. doi: 10.1080/ 01635581.2012.717676 PMID: 23061912
22. Wan Y, Xin Y, Zhang C, Wu D, Ding D, Tang L, et al. Fermentation supernatants of Lactobacillus delbrueckii inhibit growth of human colon cancer cells and induce apoptosis through a caspase 3-dependent pathway. Oncol Lett. 2014; 7(5): 1738-1742. PMID: 24765211
23. Chen CC, Lin WC, Kong MS, Shi HN, Walker WA, Lin CY, et al. Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue. Br J Nutr. 2012; 107(11): 1623-1634. doi: 10.1017/S0007114511004934 PMID: 21992995
24. Kim Y, Oh S, Yun HS, Oh S, Kim SH. Cell-bound exopolysaccharide from probiotic bacteria induces autophagic cell death on tumour cells. Lett Appl Microbiol. 2010; 51: 123-130. doi: 10.1111/j.1472-765X.2010.02859.x PMID: 20536712
25. Hirayama K, Rafter J. The role of probiotic bacteria in cancer prevention. Microbes Infect. 2000; 2(6): 681-686. PMID: 10884619
26. Hirayama K, Rafter J. The role of probiotic bacteria in cancer prevention. Microbes Infect. 2000; 2(6): 681-686. PMID: 10884619
27. Kim JE, Kim JY, Lee KW, Lee HJ. Cancer chemopreventive effects of lactic acid bacteria. J Microbiol Biotechnol. 2007; 17(8): 1227-1235. PMID: 18051589
28. Kumar M, Kumar A, Nagpal R, Mohania D, Behare P, Verma V, et al. Cancer-preventing attributes of probiotics: an update. Int J Food Sci Nutr. 2010; 61(5): 473-496 doi: 10.3109/09637480903455971 PMID: 20187714
29. Khazaie K, Zadeh M, Khan MW, Bere P, Gounari F, Dennis K, et al. Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci USA. 2012; 109(26): 10462-10467. doi: 10.1073/pnas.1207230109 PMID: 22689992
30. Uccello M, Malaguarnera G, Basile F, D'agata V, Malaguarnera M, Bertino G, et al. Potential role of probiotics on colorectal cancer prevention. BMC Surg. 2012; 12(S1): S35
31. Kato I, Kobayashi S, Yokokura T, Mutai M. Antitumor activity of Lactobacillus casei in mice. Gan. 1981; 72(4): 517-523. PMID: 6796451
32. Kato I, Endo K, Yokokura T. Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. Int J Immunopharmacol. 1994; 16(1): 29-36. PMID: 8150553
33. Matsuzaki T, Yokokura T, Azuma I. Anti-tumour activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs. Cancer Immunol Immunother. 1985; 20(1): 18-22. PMID: 3933816
34. Lee JW, Shin JG, Kim EH, Kang HE, Yim IB, Kim JY, et al. Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J Vet Sci. 2004; 5 (1): 41-48. PMID: 15028884
35. Seow SW, Cai S, Rahmat JN, Bay BH, Lee YK, Chan YH, et al. Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors. Cancer Sci. 2010; 101(3): 751-758. doi: 10.1111/j.1349-7006.2009.01426.x PMID: 20015287
36. Fang J, Liao L, Yin H, Nakamura H, Shin T, Maeda H. Enhanced bacterial tumor delivery by modulating the EPR effect and therapeutic potential of Lactobacillus casei. J Pharm Sci. 2014; 103(10): 3235-3243. doi: 10.1002/jps.24083 PMID: 25041982
37. Wang K, Li W, Rui X, Chen X, Jiang M, Dong M. Characterization of a novel exopolysaccharide with antitumor activity from Lactobacillus plantarum 70810. Int J Biol Macromol. 2014; 63: 133-139. doi: 10.1016/j.ijbiomac.2013.10.036 PMID: 24189393
38. Ishikawa H, Akedo I, Otani T, Suzuki T, Nakamura T, Takeyama I, et al. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer. 2005; 116 (5): 762-767. PMID: 15828052
39. Gianotti L, Morelli L, Galbiati F, Rocchetti S, Coppola S, Beneduce A, et al. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World J Gastroenterol. 2014; 16(2): 167-175.
40. Kourkoutas Y, Bosnea L, Taboukos S, Baras C, Lambrou D, Kanellaki M. Probiotic cheese production using Lactobacillus casei cells immobilized on fruit pieces. J Dairy Sci. 2006; 89: 1439-1451. PMID: 16606715
41. Sidira M, Galanis A, Ypsilantis P, Karapetsas A, Progaki Z, Simopoulos C, et al. Effect of probiotic-fermented milk administration on gastrointestinal survival of Lactobacillus casei ATCC 393 and modulation of intestinal microbial flora. J Mol Microbiol Biotechnol. 2010: 19(4): 224-230. doi: 10.1159/ 000321115 PMID: 21160205
42. Sidira M, Saxami G, Dimitrellou D, Santarmaki V, Galanis A, Kourkoutas Y (2013). Monitoring survival of Lactobacillus casei ATCC 393 in probiotic yogurts using an efficient molecular tool. J Dairy Sci. 2013; 96(5): 3369-3377. doi: 10.3168/jds.2012-6343 PMID: 23498002
43. Sidira M, Karapetsas A, Galanis A, Kanellaki M, Kourkoutas Y. Effective survival of immobilized Lactobacillus casei during ripening and heat treatment of probiotic dry-fermented sausages and investigation of the microbial dynamics. Meat Sci. 2014; 96: 948-955. doi: 10.1016/j.meatsci.2013.09.013 PMID: 24211554
44. Fogh J. Human tumor cells in vitro. New York: Plenum Press; 1975.
45. Corbett TH, Griswold DP Jr, Roberts BJ, Peckham JC, Schabel FM Jr. Tumor induction relationships in development of transplantable cancers of colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res. 1975; 35: 2434-2439. PMID: 1149045
46. Castle JC, Loewer M, Boegel S, de Graaf J, Bender C, Tadmor AD, et al. Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma. BMC Genomics. 2014; 15: 190. doi: 10.1186/1471-2164-15-190 PMID: 24621249
47. Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006; 1(3): 1113-1116.
48. Bianchi MA, Del Rio D, Pellegrini N, Sansebastiano G, Neviani E, Brighenti F. A fluorescence-based method for the detection of adhesive properties of lactic acid bacteria to Caco-2 cells. Lett Appl Microbiol. 2004; 39(3): 301-305. PMID: 15287879
49. Kodaikkal V, Prajapati JB, Ljungh A. Evaluation of adhesion of Lactobacillus strains to HT-29 cells by a flow cytometric assay. Int J Appl Anim Sci. 2012; 1: 1-7.
50. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J Immunol Meth. 1995; 184: 39-51.
51. Clarke RG, Lund EK, Johnson IT, Pinder AC. Apoptosis can be detected in attached colonic adenocarcinoma HT29 cells using annexin V binding, but not by TUNEL assay or sub-G0 DNA content. Cytometry. 2000; 39(2): 141-150. PMID: 10679732
52. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008; 3(6): 1101-1108. PMID: 18546601
53. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009; 9(5): 313-324. doi: 10.1038/nri2515 PMID: 19343057
54. Escamilla J, Lane MA, Maitin V. Cell-free supernatants from probiotic Lactobacillus casei and Lactobacillus rhamnosus GG decrease colon cancer cell invasion in vitro. Nutr Cancer. 2012; 64(6): 871-878. doi: 10.1080/01635581.2012.700758 PMID: 22830611
55. Di Luccia B, Manzo N, Baccigalupi L, Calabrò V, Crescenzi E, Ricca E, et al. Lactobacillus gasseri SF1183 affects intestinal epithelial cell survival and growth. PLoS One. 2013; 8(7): e69102. doi: 10.1371/journal.pone.0069102 PMID: 23894414
56. Lan A, Lagadic-Gossmann D, Lemaire C, Brenner C, Jan G. Acidic extracellular pH shifts colorectal cancer cell death from apoptosis to necrosis upon exposure to propionate and acetate, major end-products of the human probiotic propionibacteria. Apoptosis. 2007; 12(3): 573-591. PMID: 17195096
57. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007; 35(4): 495-516. PMID: 17562483
58. Iyer C, Kosters A, Sethi G, Kunnumakkara AB, Aggarwal BB, Versalovic J. Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia derived cells by modulation of NFkappa B and MAPK signaling. Cell Microbiol. 2008; 10: 1442-1452. doi: 10.1111/j.1462-5822.2008. 01137.x PMID: 18331465
59. Baldwin C, Millette M, Oth D, Ruiz MT, Luquet FM, Lacroix M. Probiotic Lactobacillus acidophilus and L. casei mix sensitize colorectal tumoral cells to 5-fluorouracil-induced apoptosis. Nutr Cancer. 2010; 62(3): 371-378. doi: 10.1080/01635580903407197 PMID: 20358475
60. Pagnini C, Saeed R, Bamias G, Arseneau KO, Pizarro TT, Cominelli F. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci USA. 5; 107(1): 454-459. doi: 10.1073/pnas.0910307107 PMID: 20018654
61. Galligan L, Longley DB, McEwan M, Wilson TR, McLaughlin K, Johnston PG. Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors and c-FLIP. Mol Cancer Ther. 2005; 4: 2026-2036. PMID: 16373718
62. Falschlehner C, Schaefer U, Walczak H. Following TRAIL's path in the immune system. Immunology. 2009; 127: 145-154. doi: 10.1111/j.1365-2567.2009.03058.x PMID: 19476510
63. Horinaka M, Yoshida T, Kishi A, Akatani K, Yasuda T, Kouhara J, et al. Lactobacillus strains induce TRAIL production and facilitate natural killer activity against cancer cells. FEBS Lett. 2010; 584: 577-582. doi: 10.1016/j.febslet.2009.12.004 PMID: 19995562
64. Ishii M, Iwai M, Harada Y, Kishida T, Asada H, Shin-Ya M, et al. Soluble TRAIL gene and actinomycin D synergistically suppressed multiple metastasis of TRAIL-resistant colon cancer in the liver. Cancer Lett. 2007; 245: 134-143. PMID: 16478647
65. van Geelen CM, Pennarun B, Le PT, de Vries EG, de Jong S. Modulation of TRAIL resistance in colon carcinoma cells: different contributions of DR4 and DR5. BMC Cancer. 2011; 11: 39. doi: 10.1186/ 1471-2407-11-39 PMID: 21272366
66. Stolfi C, Caruso R, Franze E, Rizzo A, Rotondi A, Monteleone I et al. 2-Methoxy-5-Amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression. Mol Cancer Ther. 2011; 10(10): 1969-1981. doi: 10.1158/1535-7163.MCT-11-0316 PMID: 21817114
67. Raviv Z, Zilberberg A, Cohen S, Reischer-Pelech D, Horrix C, Berger MR, et al. Methyl jasmonate down-regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL-induced cytotoxicity. Br J Pharmacol. 2011; 164: 1422-1444.
68. Sung B, Ravindran J, Prasad S, Pandey MK, Aggarwal BB. Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL. J Biol Chem. 2010; 285: 35418-35427. doi: 10.1074/jbc.M110.172767 PMID: 20837473
69. Diao Z, Shi J, Zhu J, Yuan H, Ru Q, Liu S, et al. TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4+CD25+ Treg apoptosis. Cancer Immunol Immunother. 2013; 62: 653-663. doi: 10.1007/s00262-012-1370-x PMID: 23143747